biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > Forcing Bioasis to Answer

<< Previous

Bullboard Posts

Next >>

Comment by Boomskidon Jan 16, 2023 6:30pm

92 Views

Post# 35226722

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Forcing Bioasis to Answer

poof says, "To me this looks like a takeover of Midatech by Bioasis."

I can't help but imagine that even poof was giggling after he wrote that line. He is capable of sufficient hubris.to think he could get away with it.

I guess it's a time when a good laugh is a good thing.

Ha ha.

Ha

jd

<< Previous

Bullboard Posts

Next >>

Options trading in a volatile macro environment